3-Bromopyruvic acid is a brominated derivative of pyruvic acid (sc-208191), which inhibits HXK II (hexokinase II) in cancer cells. As a result of this inhibition the cells are unable to metabolize glucose into ATP directly. Studies conducted on MCF-7 (sc-2206) breast cancer cells show that 3-Bromopyruvic acid hydrate reduces the expression of Bcl-2, c-Myc and mutant p53, which are involved in the cell death signal transduction pathway. Alternate studies indicate that 3-Bromopyruvic acid hydrate is a very selective antibiotic, inhibiting the growth of certain yeasts.
1. ZYGMUNT, W.A. and MARTIN, T.A. 1964. J Pharm Sci. 53 : 1420-1421. PMID: 14253613
2. Liu, X.H. et al. 2009. Chin. Med. J. 122(14): 1681-1685. PMID: 19719971
Test | Specification | Results |
---|---|---|
Appearance | Light beige powder | |
Purity (Acid Titration) | 98.3% |
See how others have used 3-Bromopyruvic acid (CAS 1113-59-3). Click on the entry to view the PubMed entry .
PMID: 36559193 | Suppressing of Src-Hic-5-JNK-AKT Signaling Reduced GAPDH Expression for Preventing the Progression of HuCCT1 Cholangiocarcinoma. | Wu, WS. et al. 2022. Pharmaceutics. 14:
PMID: 28965765 | MYC Controls Human Pluripotent Stem Cell Fate Decisions through Regulation of Metabolic Flux. | Cliff, TS. et al. 2017. Cell Stem Cell. 21: 502-516.e9.
PMID: 26795347 | miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors. | Bacci, M. et al. 2016. Cancer Res. 76: 1615-26.
PMID: 27723751 | Nuclear receptors control pro-viral and antiviral metabolic responses to hepatitis C virus infection. | Levy, G. et al. 2016. Nat. Chem. Biol. 12: 1037-1045.
PMID: 32615946 | | BMC Cancer. 617.
PMID: 32125743 | Intracellular ATP levels influence cell fates in Dictyostelium discoideum differentiation. | Genes Cells.
PMID: 31669882 | | Pharmacol Rep. 1184-1189.